Event Overview

Thanks to advances in techniques for culturing and genetically modifying patient cells, scientists developed myriad stem cell-based treatments for human diseases. Therapeutic success rates for stem cell-based treatments depend on whether scientists can provide the proper structural and molecular cues to form the cell types lacking in patients. In addition, to support successful engraftment, researchers must devise ways to bypass immune rejection.

In this webinar brought to you by The Scientist’s Creative Services Team, Kim Vanuytsel and Ryan Flannigan discuss the cutting-edge technologies they incorporate to improve stem cell-based therapies for various disorders, including cancer and infertility.

Topics to be covered

  • Multi-omic profiling reveals a molecular signature of human fetal liver hematopoietic stem cell engraftment potential
  • Developing in vitro platforms to restore sperm production using 3-D bio-printing

  • Tuesday, August 9, 2022

    3:00 - 4:30 PM Eastern Time 

    This webinar will also be available on-demand.

    Meet the speakers

    Kim Vanuytsel, PhD
    Research Assistant Professor
    Department of Medicine
    Center for Regenerative Medicine
    Boston University School of Medicine
    Ryan Flannigan, MD
    Assistant Professor
    Department of Urologic Sciences
    University of British Columbia
    Adjunct Clinical Assistant Professor
    Department of Urology
    Weill Cornell Medicine
    Sponsored by






    You must have Javascript and Cookies enabled to access this webcast.

    Information you provide will be shared with the sponsors for this content. The Scientist or its sponsors may contact you to offer you content or products based on your interest in this topic. You may opt-out at any time.